US 5,919,965 A · Non-nucleotide phosphorus ester oligomers

Abstract

A phosphorus ester oligomer having the structure: ##STR1## wherein A can be the same or different in each monomeric unit and each is independently selected from the group consisting of oxygen, sulfur, lower alkyl, alkyl- or aryl-substituted amino and aminoalkyl; B.sub.1 and B.sub.2 can be the same or different and each is independently selected from hydrogen, lower alkyl, a labelling group, a protecting group, a phosphoramidate or a phosphomonoester; R.sub.1 can be the same or different in each monomeric unit, and in at least one of the non-nucleotide monomeric units, R.sub.1 is independently selected from the group consisting of a condensation product of (i) a non-vicinal diol attached to a hydrogen bond donor functionality; (ii) a hydrogen bond acceptor selected from an ether, a purine or pyrimidine substituted 1,2-diol or a disubstituted heterocycle; (iii) a non-vicinal diol attached to a hydrophobic functionality or a vicinal diol attached to an aliphatic or alicyclic hydrophobic functionality (iv) a diol attached to a ring substituted anionic functionality and (v) a cationic moiety attached to a non-vicinal or alicyclic diol, any of which can further include a detectable label, and n is at least one. Preferred R.sub.1 moieties include condensation products of heterocyclic diols, alicyclic diols, and polycyclic diols. Also the non-nucleotide monomers thereof, combinatorial library mixtures of the oligomers and the use of the oligomers as selective target-binding compounds.

Claims5

Dependent claims

A phosphorus ester oligomer of monomeric units, which oligomer has the structure:

##STR68## wherein A is the same or different in each monomeric unit and each is independently selected from the group consisting of oxygen, sulfur, lower alkyl, substituted or unsubstituted alkylamino, substituted or unsubstituted arylamino and aminoalkyl;
B.sup.1 and B.sup.2 are the same or different and each is independently selected from hydrogen, lower alkyl, a detectable label, a protecting group, a phosporamidate or a phosphomonoester;
R.sup.1 is the same or different in each monomeric unit, and in at least one of the monomeric units is independently selected from a condensation product of
(i) an aliphatic acyclic diol wherein the diol hydroxyl groups are non-vicinal or are substituted;
(ii) a purine- or pyrimidine-substituted variant of the diols of (i) or of aliphatic acyclic vicinal diols;
(iii) an acyclic aliphatic diol having an amino group with at least one hydrogen substitution moiety;
(iv) an alicyclic or polycyclic diol, optionally substituted with a carboxy or carboxyalkyl substituent;
(v) an indole-substituted acyclic aliphatic diol;
(vi) an aromatic ring or ring system having two substitutions independently selected from the group consisting of hydroxy or hydroxyalkyl;
and
(vii) a heterocyclic compound having two substitutions independently selected from the group consisting of hydroxy or hydroxyalkyl;
any of which can further include a detectable label;
and
n is at least two.

11 more elements

Dependencies are inferred from the claim text.

Non-nucleotide phosphorus ester oligomers

Life of this patent

Non-nucleotide phosphorus ester oligomers

Life of this patent

Abstract

Claims5